Tacrolimus (FK 506) is a new, potent immunosuppressive drug for primary and rescue therapy in liver and kidney transplantation. Therapeutic drug monitoring is essential for this drug because of its narrow therapeutic window. Blood levels are monitored routinely by enzyme linked immunoassay (ELISA) or by microparticle enzyme immunoassay (MEIA). In a 13-year-old recipient of a liver transplant who had poor hepatic function during the first postoperative week, the authors observed unusually high tacrolimus blood concentrations using either the ELISA (26.6 to 49.0 microg/l) or MEIA (58.5 to 64.5 microg/l). Parent drug levels measured in the same blood samples by high-performance liquid chromatography/mass spectrometry (HPLC/MS) were up to 10-fold lower (5.1 to 9.0 microg/l). The discrepancies between the immunoassay and HPLC/MS results could not be attributed to any of the known metabolites of tacrolimus.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00007691-199712000-00004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Novel Approach to Peripheral Nerve Regeneration: Local FK-506 Delivery Using a Reservoir Flap Model.
Yonsei Med J
December 2024
Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea.
Purpose: Peripheral nerve injuries can lead to lasting functional impairments, impacting movement and quality of life. FK-506, a widely used immunosuppressant, has demonstrated potential in promoting nerve regeneration in addition to its immunosuppressive effects. This study investigates the use of a local reservoir flap to deliver FK-506 directly to the nerve injury site, aiming to enhance nerve regeneration while minimizing systemic immunosuppression.
View Article and Find Full Text PDFTacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation.
World J Transplant
June 2024
Division of Gastroenterology and Hepatology, East Carolina University/Brody School of Medicine, Greenville, NC 27858, United States.
Article Synopsis
- The editorial discusses a condition called posterior reversible encephalopathy syndrome (PRES) that can happen to people who have had liver transplants and are treated with a medicine called Tacrolimus.
- Tacrolimus helps prevent the body from rejecting the new liver, but it can cause problems like PRES, which leads to symptoms like high blood pressure, seizures, and vision issues.
- The article emphasizes that doctors need to recognize and diagnose PRES early to help patients feel better and manage the risks from using Tacrolimus.
Post-transplant lymphoproliferative disorder associated Epstein-Barr virus DNAemia after liver transplantation in children: Experience from single center.
J Med Virol
June 2024
Division of Gastroenterology, Hepatology, and Nutrition Disease, Department of Pediatrics, Medical School of Ege University, İzmir, Türkiye.
Article Synopsis
- Post-transplant lymphoproliferative disorder (PTLD) is a serious complication that can occur after solid organ transplants, particularly in pediatric liver transplant recipients.
- A study conducted on 112 pediatric patients revealed that 43.75% developed Epstein-Barr virus (EBV) DNAemia, with 8 of these patients subsequently diagnosed with PTLD.
- Findings showed that age at diagnosis of EBV DNAemia, as well as abnormal test results, were significantly higher in PTLD patients, indicating a correlation between older age and the development of this complication.
Optimum tacrolimus trough levels for enhanced graft survival and safety in kidney transplantation: a retrospective multicenter real-world evidence study.
Int J Surg
October 2024
Division of Transplantation and Vascular Surgery, Department of Surgery, Seoul National University Hospital, Seoul.
Article Synopsis
- The study investigates the best tacrolimus trough levels to maximize kidney transplant success and minimize patient risks across a large cohort of 11,868 recipients from five medical centers.
- Findings suggest that maintaining tacrolimus levels between 5.0-7.9 ng/mL in the first two years post-transplant decreases risks of graft failure and severe complications like infections and malignancies.
- The research supports specific tacrolimus dosage guidelines, aiming to improve long-term outcomes for kidney transplant patients.
The Role of FKBPs in Complex Disorders: Neuropsychiatric Diseases, Cancer, and Type 2 Diabetes Mellitus.
Cells
May 2024
Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, The Zlotowski Center for Neuroscience and Zelman Center-The School of Brain Sciences and Cognition, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Stress is a common denominator of complex disorders and the FK-506 binding protein (FKBP)51 plays a central role in stress. Hence, it is not surprising that multiple studies imply the involvement of the FKBP51 protein and/or its coding gene, , in complex disorders. This review summarizes such reports concentrating on three disorder clusters-neuropsychiatric, cancer, and type 2 diabetes mellitus (T2DM).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!